CD4+ T cells act in a bidirectional regulatory network with B cells to induce differentiation of B cells which in turn, stimulates CD4+ TH1 and TH2 differentiation, suggesting the clinical significance of these immune cells for anti-tumor response. The gene discussed is CD4; the disease is neoplasm.